NCT05918913 2025-09-05Expanded Access Program for RevumenibSyndax PharmaceuticalsNo longer available1 FDA
NCT03145545 2025-05-22Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSCChildren's Hospital of PhiladelphiaAvailable